Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Oral glucose tolerance test (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University Hospital Basel, Division of Gastroenterology and Hepatology
  Basel, Switzerland
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Sitagliptin (drug) — also listed as: Other name is known

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Nobumasa Ohara
  Niigata, Niigata, Japan
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Liraglutide (drug)
• Placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Gentofte Hospital
  Hellerup, Denmark
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• PYY 3-36 (biological)
• GLP-1 (biological)
• saline infusion (biological)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Human Nutrition, Faculty of Life Sciences, University of Copenhagen
  Copenhagen, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Liraglutide (drug) — also listed as: Novonordisk (Puteaux, France)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• CHU Dijon
  Dijon, Bourgogne-Franche-Comté, France
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Dipeptidyl Peptidase IV inhibitors (drug) — also listed as: Januvia (Merck Sharp Dome), Sitagliptin

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of São Paulo General Hospital
  São Paulo, São Paulo, Brazil
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Placebo (drug)
• LY2409021 (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
  Singapore, Singapore
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• liraglutide (drug)
• Insulin injections (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Conventional continuous subcutaneous insulin infusion therapy (device)
• Dual-hormone closed-loop (device)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Institut de Recherches Cliniques de Montréal (IRCM)
  Montreal, Quebec, Canada
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• glibenclamide (drug) — also listed as: Daonil 5 mg pills
• placebo (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University Hospital Basel
  Basel, Basel, Switzerland
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GLP 1 (biological)
• normal saline solution placebo (biological)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University of Pennsylvania
  Philadelphia, Pennsylvania, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• dipeptidyl peptidase 4 (DPP4) inhibitor (drug) — also listed as: Galvus
• oral glucose (other) — also listed as: Panodil
• intravenous glucose (other) — also listed as: Panodil

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Internal Medicine F' laboratory
  Hellerup, Copenhagen, Denmark
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• sitagliptin, metformin (drug) — also listed as: Januvia

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Seoul National University Bundang Hospital
  Seongnam-si, Gyeonggi-do, South Korea
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• GLP-1 (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Mayo Clinic
  Rochester, Minnesota, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Section of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital
  Taipei, Taiwan
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Intralipid +/- Omegaven (dietary_supplement) — also listed as: Fresenius Kabi, ATC main group B05B A 02, Intralipid Vnr 42 79 55, Omegaven Vnr 55 25 54

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Medicine, Division of Endocrinology, St. Olavs Hospital
  Trondheim, Norway
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• ensure plus (dietary_supplement)
• standardized test meal (dietary_supplement)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• University Hospital Basel, Phase 1 Research Unit
  Basel, Canton of Basel-City, Switzerland
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• exendin(9-39)amide (drug)
• saline (drug)
• duodenal meal (other)
• duodenal saline (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Ludwig Maximilians-University, Clinical Research Unit
  Munich, Germany
  Site recruitment: Not reported
• Clinical Research unit, Dept. of Internal Medicine II - Großhadern, University of Munich
  Munich, Germany
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Insulin, Asp(B28)- (drug) — also listed as: Aspart insulin, Novolog
• Glucagon (drug) — also listed as: Glucagen
• Placebo (drug) — also listed as: Normal saline, NaCl 0.9%

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Legacy Research
  Portland, Oregon, United States
  Site recruitment: Not reported